Gilead Sciences, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 32,858 | 0.3% | 267,702 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 29,360 | 0.3% | 264,502 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 29,890 | 0.3% | 269,598 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 36,673 | 0.4% | 327,290 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 30,356 | 0.3% | 328,640 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 42,156 | 0.4% | 502,814 | 9/30/2024 |
| 2024 Q2 | 7/24/2024 | 37,666 | 0.4% | 548,988 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 37,918 | 0.5% | 517,656 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 40,110 | 0.6% | 495,130 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 35,868 | 0.7% | 478,625 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 20,724 | 0.4% | 268,894 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 17,071 | 0.3% | 205,745 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 17,663 | 0.5% | 205,745 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 16,894 | 0.7% | 273,848 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 20,190 | 0.7% | 326,641 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 23,634 | 0.7% | 397,542 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 24,876 | 0.8% | 342,603 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 23,967 | 0.9% | 343,125 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 24,994 | 0.9% | 362,981 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 23,304 | 1.1% | 360,584 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 20,144 | 1.2% | 345,770 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 17,907 | 1.4% | 283,392 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 17,007 | 1.2% | 221,052 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 17,741 | 1.5% | 237,297 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 28,261 | 1.8% | 434,918 | 12/31/2019 |